Investigators calculated annual OOP and total medication costs for five common neurological diseases. These included 186,144 ...

Chemotherapy for three months demonstrates lower side effects, suggesting its use as standard care compared with six months.

Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, ...

Research shows neuropathy can be more severe and more common in Black breast cancer patients, causing doctors to dial back ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is excited to announce that its novel oral ketamine analog, Ketamir-2, has shown greater pain ...

Approximately 70 percent of patients respond well to medication and go into remission. For those who did not respond well to medication, surgery is an option. The most common medication option is anti ...

A Johns Hopkins obstetrician discusses some common pregnancy complications and how they can be managed ... HG can lead to not getting enough nutrients, which can be harmful to both you and your baby.

This form of neuropathy carries a high risk of pain, trophic changes and autonomic dysfunction. There is currently no effective treatment for diabetic neuropathy, and good glycemic control is the ...

However, sometimes, B 1 deficiency may develop in the brain and other vital organs as a side effect of some drugs. This can happen despite normal B 1 levels in the blood, which often makes such ...

Although sexual assault cases involving alcohol are far more common, the unique danger of these drugs lies in their ability to incapacitate victims without their knowledge, often making it ...

Neuropathy, a common condition affecting millions, can lead to symptoms such as numbness ... especially for individuals with pre-existing conditions or those taking medications. Bacopa Monnieri, also ...